Nolvadex is given for breast cancer



NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer. Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters

Full Post: High insulin levels may increase breast cancer risk

Nolvadex is given for breast cancer. The medicine is also given for preventing cancer, which has spread to other parts.

Once Nolvadex is prescribed, you should have to strictly follow the prescription. The drug could be taken with or without food. Never crush, chew or break the drug but only swallow the drug as it has to be slowly released into the body. Moreover, never stop the drug in the middle of a dosage as it can only lead to many complications.

If you have missed a dose, never take it and continue with the next dosages. Never go for a double dosage as it can only increase the risk of side effects.

When you consult the doctor, discuss with him about all your medical conditions so that he will be able to properly decide on the prescription. Inform the physician if you have high levels of calcium, cholesterol and lipid levels, history of blood clots, weak immune system, low white blood cell and platelet counts and problems of vision.

Pregnant women and breast-feeding women should not take Nolvadex as the drug may cause harm to the foetus and the newborn babe.

The drug is not prescribed if you are using anticoagulants, rifampin, mitomycin C, fluorouracil and Aromatase inhibitors. After taking Nolvadex, be cautious if you are driving or performing any hard task as the drug is known to cause dizziness. Never consume alcohol while you are on Nolvadex medication.

Never get hurt while taking Nolvadex as the drug is known to lower the platelets count. Moreover, do not come in contact with any person who has infection.

www.nolvadexwithoutprescription.net

--------------------------------------------------------------------------------------------
Related Posts:


Arimidex is prescribed for treating hormone receptor positive disease (metastatic breast cancer) and early-stage breast cancer after surgery in postmenopausal women. While taking Arimidex, follow the doctor’s direction. The prescribed normal dosage is one pill a day. It is also advised not to take larger doses of the drug and also not to take it for

Full Post: Arimidex is prescribed for treating early-stage breast cancer
--------------------------------------------------------------------------------------------

Do you know that breast cancer is the most common cancer among women? Breast cancer is also the second leading cause of cancer related deaths in American women. Most cases of breast cancer are diagnosed when a mammogram reveals a lump. A change in the texture of breast tissue can also be a warning sign

Full Post: Nolvadex PCT
--------------------------------------------------------------------------------------------

Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer.Half of the women failed to finish a five year course of the drug and one in five regularly forget to take a tablet.Experts already know that taking

Full Post: Women risk their lives by failing to take breast cancer drugs
--------------------------------------------------------------------------------------------

Wednesday October 29, 2008 (foodconsumer.org) — A new Korean study published on Oct 9 in Archives of Toxicology suggests that ingestion of bisphenol A or BPA may not increase risk of breast cancer. The study led by Yang M at Sookmyung Women’s University in Seoul, Republic of Korea found there was no significant difference in

Full Post: Could BPA raise breast cancer risk?
--------------------------------------------------------------------------------------------

Wednesday October 29, 2008 (foodconsumer.org) — A new Korean study published on Oct 9 in Archives of Toxicology suggests that ingestion of bisphenol A or BPA may not increase risk of breast cancer. The study led by Yang M at Sookmyung Women’s University in Seoul, Republic of Korea found there was no significant difference in

Full Post: Could BPA raise breast cancer risk?